USTR Tai: US to back waiver of vaccine IP protections at WTO
|The US will support a proposal to waive intellectual property protections for COVID-19 vaccines, in order to increase global supply and access to the life-saving shots, the country’s Trade Representative Katherine Tai said in an interview on Wednesday.
Key quotes
“We are for the waiver at the WTO, we are for what the proponents of the waiver are trying to accomplish, which is better access, more manufacturing capability, more shots in arms.”
“In terms of how soon the WTO can deliver -- that literally depends on the WTO members, collectively, being able to deliver, and so I am the first one to admit that what we are leaning into is a process that is not going to be easy.”
“Sees energy from WTO Director-General Ngozi Okonjo-Iweala “to take this opportunity and see what is the WTO capable of.”
Market reaction
In reaction to the above comments, Shares of Moderna Inc., Pfizer Inc., BioNTech SE and Novavax Inc, as drugmakers believe that the plan is ineffective.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.